DNA repair capacity and cisplatin sensitivity of human testis tumour cells

International Journal of Cancer

Volumn 70, Issue 5, 1997, Pages 551-555

  Köberle, Beate ^a   Grimaldi, Keith A ^b   Sunters, Andrew ^b   Hartley, John A ^b   Kelland, Lloyd R ^c   Masters, John R W ^a  

^a INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ARTICLE; BLADDER CANCER; CONTROLLED STUDY; DNA DRUG COMPLEX; DNA REPAIR; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; TESTIS TUMOR;

EID: 1842409546     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G     Document Type: Article

References (32)

1. BEDFORD, P., FICHTTNGER-SCHEPMAN, A.M.J., SHELLARD, S.A., WALKER, M.C., MASTERS, J.R.W. and HILL, B.T., Differential repair of platinum-DNA adducts in human bladder and testicular tumour continuous cell lines. Cancer Res., 48, 3019-3024 (1988).
2. BOHR, V., Gene specific DNA repair. Carcinogenesis, 12, 1983-1992 (1991).
3. BOHR, V., OKUMOTO, D.S. and HANAWALT, P.C., Survival of UV-irradiated mammalian cells correlates with efficient DNA repair in essential genes. Proc. nat. Acad. Sci. (Wash.), 83, 3830-3833 (1986).
4. CHRESTA, C.M., MASTERS, J.R.W. and HICKMAN, J.A., Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and hish Bax:Bcl-2 ratio. Cancer Res., 56, 1834-1841 (1996).
5. EASTMAN, A., Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). Biochemistry, 22, 3927-3933 (1983).
6. EINHORN, L.H., Treatment of testicular cancer: a new and improved model. J. Clin. Oncol., 8, 1777-1781 (1990).
7. FUTSCHER, B.W. and ERICKSON, L.C., Changes in c-myc and c-fos expression in a human tumour cell line following exposure to bifunctional alkyiating agents. Cancer Res., 50, 62-66 (1990).
8. GRIMALDI, K.A., BINGHAM, J.P., SOUHAMI, R.L. and HARTLEY, J.A., DNA damage by anticancer agents: mapping in cells at the subgene level with quantitative PCR. Analyt. Biochem., 222, 236-242 (1994).
9. HILL, B.T., SCANLON, K.J., HANSSON, J., HARSTRICK, A., PERA, M., FICHTINGER-SCHEPMAN, A.M.J. and SHELLARD, S.A., Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients. Europ. J. Cancer, 30A, 832-837 (1994).
10. ISLAS, A.L., Vos, J.M.H. and HANAWALT, P.C., Differential induction and repair of psoralen photoadducts to DNA in specific human genes. Cancer Res., 51, 2867-2873 (1991).
11. JOHNSON, S.W., PEREZ, R.P. GODWIN, A.K., YEUNG, AT., HANDEL, L.M., OZOLS, R.F. and HAMILTON, T.C., Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem. Pharmacol., 47, 689-697 (1994).
12. JONES, J.C., ZHEN, W., REED, F., PARKER, R.J., SANCAR, A. and BOHR, V.A., Gene specific formation and repair of cisplatin intrastrand adducts and interstrand crosslinks in Chinese hamster ovary cells. J. biol. Chem., 266, 7101-7107 (1991).
13. KELLAND, L.R., MISTRY, P., ABEL, G., FREIDLOS, F., LOH, S.Y., ROBERTS, J.J. and HARRAP, K.R., Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous cell line. Cancer Res., 52, 1710-1716 (1992).
14. KÖBERLE, B., PAYNE, J., GRIMALDI, K.A., HARTLEY, J.A. AND MASTERS, J.R.W. DNA repair in cisplatin-sensitive and resistant human cell lines measured in specific genes by quantitative polymerase chain reaction. Biochem. Pharmacol. 52, 1729-1734 (1996).
15. LEE, K.B., PARKER, R.J., BOHR, V., CORNELISON, T. and REED, E., Cisplatin sensitivity/resistance in UV repair deficient Chinese hamster ovary cells of complementation groups 1 and 3. Carcinogenesis. 14, 2177-2180 (1993).
16. LINK, C.J., BURT, R.K. and BOHR, V.A., Gene specific repair of DNA damage induced by UV irradiation and cancer chemotherapeutics. Cancer Cells, 3, 427-436 (1991).
17. LOWE, S.W., RULEY, H.E., JACKS, T. and HOUSMAN, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967 (1993).
18. MASTERS, J.R.W., OSBORNE, E.J., WALKER, M.C. and PARRIS, C.N., Hypersensitivity of human testis-tumour cell lines to chemotherapeutic drugs. Int. J. Cancer, 53, 340-346 (1993).
19. PARRIS, C.N., ARLETT, C.F., LEHMANN, A.R., GREEN, M.H.L. and MASTERS. J.R.W., Differential sensitivities to gamma radiation of human bladder and testicular tumour cell lines. Int. J. Rad. Biol., 53, 599-608 (1988).
20. PERA, M.F., FRIEDLOS, F., MILLS, J. and ROBERTS, J.J., Inherent sensitivity of cultured human embryonal carcinoma cells to adducts of cis-diamminedi- chloroplatinum(II) on DNA. Cancer Res., 47, 6810-6813 (1987).
21. PERA, M.F., KÖBERLE, B. and MASTERS, J.R.W., Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolamide. Brit. J. Cancer. 71, 904-906 (1995).
22. SARK, M.W.J., TIMMER-BOSSCHA, H., MEIJER, C., UGES, D.R.A., SLUITER, W.J., PETERS, W.H.M., MULDER, N.H. and DEVRIES, E.G.E., Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma lines. Brit. J. Cancer, 71, 684-690 (1995).
23. SEIDMAN, A.D. and SCHER, H.I., The evolving role of chemotherapy for muscle infiltrating bladder cancer. Semin. Oncol., 18, 585-595 (1991).
24. SHELLARD, S.A., FICHTINGER-SCHEPPMAN, A.M.J., LAZO, J.S. and HILL, B.T., Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lungs carcinoma cell lines. Anticancer Drugs. 4, 491-500 (1993).
25. SHELLARD, S.A., HOSKING, L.K. and HILL. B.T., An anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro. Cancer Res., 51, 4557-4564 (1991).
26. TIMMER-BOSSCHA, H., TlMMER, A., MEIJER, C., DE VRIES, E.G.E., DE JONG, B., OOSTERHUIS, J.W. and MULDER, N.H., cis-Diamminedichloroplatinum-(II) resistance in vitro and in vivo in human embryonal carcinoma cell lines. Cancer Res., 53, 5705-5713 (1993).
27. VENEMA, J., BARTOSOVA, Z., NATARAJAN, A.T., VAN ZEELAND, A.A. and MULLENDERS, L.H.F., Transcription affects the rate but not the extent of repair of cyclobutane pyrimidine dimers in the human adenosine deaminase gene. J. biol. Chem., 267, 8852-8856 (1992).
28. VENEMA, J., MULLENDERS, L.H.F., NATARAJAN, A.T., VAN ZEELAND, A.A. and MAYNE, L.V., The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced damage in transcriptionally active DNA. Proc. nat. Acad. Sci. (Wash.), 87, 4707-4711 (1990b).
29. VENEMA, J., VAN HOFFEN, A., NATARAJAN, A.T., VAN ZEELAND, A.A. and MULLENDERS, L.H.F., The residual repair capacity of xeroderma pigmento-sum complementation croup C fibroblasts is highly specific for transcriptionally active DNA. Nucleic Acids Res., 18, 443-448 (1990a).
30. WALKER, M.C., PARRIS, C.N. and MASTERS, J.R.W., Differential sensitivities to chemotherapeutic drugs between testicular and bladder cancer cells. J. nat. Cancer Inst., 79, 213-216 (1987).
31. ZHEN, W., EVANS, M.E., HAGGERTY, C.M. and BOHR, V.A., Deficient gene specific repair of cisplatin-induced lesions in xeroderma pigmentosum and Fanconi's anemia cells. Carcinogenesis, 14, 919-924 (1993).
32. ZHEN, W., LINK, C.J., O'CONNOR, P.M., REED, E., PARKER, R., HOWELL, S. and BOHR, V.A., Increased gene specific repair of cisplatin interstrand crosslinks in cisplatin resistant human ovarian cancer cell lines. Mol. cell. Biol., 12, 3689-3698 (1992).